Tenax Therapeutics, Inc.
TENX
$6.00
-$0.04-0.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -203.41% | -173.97% | -94.27% | -100.84% | -223.15% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14,767.74% | 3,161.42% | 2,328.82% | -53.86% | -44.74% |
| Change in Net Operating Assets | -104.87% | 53.08% | -11.72% | 648.46% | 306.18% |
| Cash from Operations | -106.63% | -34.86% | -200.17% | -48.34% | -228.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 99.94% | -62.76% | 20.33% |
| Issuance of Common Stock | -- | 34,600.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -606.26% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 189.84% | 606.76% | 20.52% | -- |
| Cash from Financing | 307.46% | 197.40% | 138.49% | 53,815.24% | -34.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.10% | 501.96% | -156.38% | 4,048.10% | -209.90% |